Financial advisers shun Noveko, despite record demand
Home » Media Mentions » Financial advisers shun Noveko, despite record demand
May 9, 2009
The proliferation of influenza A/H1N1 has led to an explosion of orders for antimicrobial filters for respiratory masks manufactured by Noveko International (Tor., EKO, $ 1.80).
Claret Asset Management specializes in offering portfolio management services to high net worth clients. We are completely independent and free of conflicts of interest. Claret was founded in 1996 with the objective of answering the growing needs of private investors.